1. Home
  2. SSB vs CYTK Comparison

SSB vs CYTK Comparison

Compare SSB & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SouthState Corporation

SSB

SouthState Corporation

HOLD

Current Price

$106.12

Market Cap

9.9B

Sector

Finance

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$80.48

Market Cap

10.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSB
CYTK
Founded
1933
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
10.7B
IPO Year
2008
2004

Fundamental Metrics

Financial Performance
Metric
SSB
CYTK
Price
$106.12
$80.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
19
Target Price
$118.00
$89.26
AVG Volume (30 Days)
782.1K
1.8M
Earning Date
04-23-2026
05-05-2026
Dividend Yield
2.49%
N/A
EPS Growth
12.91
N/A
EPS
2.28
N/A
Revenue
N/A
$13,368,000.00
Revenue This Year
$10.07
$7.37
Revenue Next Year
$6.51
$310.19
P/E Ratio
$44.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$84.48
$32.89
52 Week High
$108.46
$88.31

Technical Indicators

Market Signals
Indicator
SSB
CYTK
Relative Strength Index (RSI) 67.49 50.24
Support Level $92.40 $59.07
Resistance Level $108.46 $88.31
Average True Range (ATR) 1.80 2.99
MACD 0.20 -0.66
Stochastic Oscillator 90.38 26.60

Price Performance

Historical Comparison
SSB
CYTK

About SSB SouthState Corporation

SouthState Bank Corp is a United States-based bank holding company. It provides a wide range of services and products to its customers through a wholly-owned bank subsidiary. The Bank provides retail and commercial banking services, mortgage lending services, trust and investment services, and consumer finance loans through financial centers in Alabama, Florida, Georgia, North Carolina, South Carolina, and Virginia. These services include demand, time, and savings deposits, lending and credit card servicing, ATM processing, and wealth management and trust services.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: